Friday, July 10, 2026

Drug profile · INN

etidronate disodium

etidronate disodium (DIDRONEL) is a atp inhibitor. Route of administration: injection. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 2
News articles 0
Drug details — etidronate disodium
US status
approved
Class
Route
INJECTION
Patents
0
Programs
2
Data quality
0.84

Quick answer

etidronate disodium (DIDRONEL) is a atp inhibitor. Route of administration: injection. Current US regulatory status: approved.

Key facts

INN etidronate disodium
Brand DIDRONEL
Mechanism ATP inhibitor
Target ATP
Route INJECTION
Formulation INJECTABLE

Mechanism of action

ATP inhibitor

Primary target: ATP

Approval history

Authority Status Date
FDA approved

Pipeline programs

  1. ETIDRONATE DISODIUM ORAL CAPSULES 400 MG Phase 3 · Disc Medicine · Pseudoxanthoma Elasticum
  2. 22U-0320 Phase 2 · Disc Medicine · Fahr's disease, Fahr's syndrome

Related & competitor drugs

  1. bempedoic acid Cardiovascular system (C10)
  2. dexlansoprazole Potassium-transporting ATPase inhibitor
  3. diazoxide Potassium channel, inwardly rectifying, subfamily J, member 11 opener
  4. esomeprazole magnesium Potassium-transporting ATPase inhibitor
  5. lansoprazole Potassium-transporting ATPase inhibitor
  6. omeprazole Potassium-transporting ATPase inhibitor

Frequently asked questions

What is etidronate disodium?

etidronate disodium (DIDRONEL) is a atp inhibitor. Route of administration: injection. Current US regulatory status: approved.

What is the brand name for etidronate disodium?

DIDRONEL is a marketed brand name for etidronate disodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of etidronate disodium?

etidronate disodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.